Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04154150 · ClinicalTrials.gov registry record · Phase 4
Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
A Phase 4 study, sponsored by Rebecca Price.
- Terminated
- Registry status
- Phase 4
- Development phase
- 16
- Enrollment target
NCT04154150 is a Phase 4 study that was terminated before completion, run by Rebecca Price. The registered enrollment target is 16 participants.
The verdict
NCT04154150, a Phase 4 study, was terminated before completion, sponsored by Rebecca Price.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 16 participants
- Enrollment target
Study Summary
This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introducing helpful information delivered by a computer-based training protocol. This work could ultimately lead to the ability to treat suicidality more efficiently and with broader dissemination by rapidly priming the brain for helpful forms of learning.
Interventions
- BEHAVIORAL Sham Training
- BEHAVIORAL Cognitive training
- DRUG Intravenous ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2019-12-19 |
| Est. Completion | 2022-03-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04154150
The ClinicalTrials.gov registry entry for NCT04154150 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rebecca Price, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sham Training is the first listed.
NCT04154150 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04154150 about?
NCT04154150 is a clinical study titled "Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot". This project seeks to identify the acute and longer-term impact of a single dose of intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in the medical inpatient setting. The investigators will then test whether ketamine's rapid effects can be extended by introd...
What is the current status of trial NCT04154150?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 16 participants. The study started on 2019-12-19. Estimated completion is 2022-03-15.
What interventions are being tested in trial NCT04154150?
The interventions under investigation include: Sham Training (BEHAVIORAL), Cognitive training (BEHAVIORAL), Intravenous ketamine (DRUG).
Who is sponsoring clinical trial NCT04154150?
This trial is sponsored by Rebecca Price, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.